Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ORP1 Polyclonal Antibody

Goat Polyclonal Antibody
Supplier: Invitrogen™ PA518219
Description
This antibody is predicted to react with bovine, canine, mouse and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 16,000.
This gene encodes a member of the oxysterol-binding protein family, a group of intracellular lipid receptors. Most members contain an N-terminal pleckstrin homology domain and a highly conserved C-terminal OSBP-like sterol-binding domain, although some members contain only the sterol-binding domain. Transcript variants derived from alternative promoter usage and/or alternative splicing exist; they encode different isoforms.
Specifications
| ORP1 | |
| Polyclonal | |
| Unconjugated | |
| OSBPL1A | |
| DCDC4A; FLJ10217; FLJ50293; FLJ55454; FLJ79410; G430090F17Rik; Gm753; ORP1; ORP-1; Orp1a; Orp1l; OSBP8; OSBPL1; OSBPL1A; OSBPL1B; OSBP-related protein 1; oxysterol binding protein like 1A; oxysterol binding protein-like 1A; oxysterol binding protein-like 1B; oxysterol-binding protein-related protein 1; oxysterol-binding protein-related protein 1 variant 1; oxysterol-binding protein-related protein 1 variant 2 | |
| Goat | |
| Ammonium Sulfate Precipitation | |
| RUO | |
| 114876 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.5 mg/mL | |
| TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
| Q9BXW6 | |
| OSBPL1A | |
| Synthetic peptide sequence (YWDRNYFNLPDIY) corresponding to the C-terminus amino acids of OSBPL1A (aa 938-950). | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction